AVANOS MEDICAL, INC Debt to Equity Ratio 2012-2022 | AVNS

Current and historical debt to equity ratio values for AVANOS MEDICAL, INC (AVNS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AVANOS MEDICAL, INC debt/equity for the three months ending June 30, 2022 was 0.20.
AVANOS MEDICAL, INC Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-06-30 $0.50B $1.25B 0.40
2022-03-31 $0.51B $1.26B 0.41
2021-12-31 $0.33B $1.26B 0.26
2021-09-30 $0.34B $1.26B 0.27
2021-06-30 $0.39B $1.30B 0.30
2021-03-31 $0.40B $1.25B 0.32
2020-12-31 $0.42B $1.26B 0.33
2020-09-30 $0.51B $1.29B 0.40
2020-06-30 $0.49B $1.26B 0.39
2020-03-31 $0.51B $1.26B 0.40
2019-12-31 $0.53B $1.27B 0.42
2019-09-30 $0.54B $1.27B 0.43
2019-06-30 $0.51B $1.28B 0.40
2019-03-31 $0.55B $1.28B 0.43
2018-12-31 $0.54B $1.30B 0.41
2018-09-30 $0.54B $1.30B 0.42
2018-06-30 $0.63B $1.29B 0.49
2018-03-31 $0.95B $1.25B 0.76
2017-12-31 $0.98B $1.22B 0.81
2017-09-30 $0.97B $1.18B 0.82
2017-06-30 $0.97B $1.16B 0.84
2017-03-31 $0.96B $1.13B 0.85
2016-12-31 $0.97B $1.10B 0.88
2016-09-30 $0.99B $1.10B 0.90
2016-06-30 $1.02B $1.09B 0.94
2016-03-31 $0.94B $1.08B 0.87
2015-12-31 $0.95B $1.06B 0.90
2015-09-30 $0.97B $1.04B 0.93
2015-06-30 $0.96B $1.52B 0.63
2015-03-31 $1.03B $1.51B 0.68
2014-12-31 $1.03B $1.49B 0.69
2014-09-30 $0.37B $2.08B 0.18
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B $0.00B 0.00
2012-12-31 $0.48B $2.06B 0.23
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.081B $0.745B
Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.023B 21.80
Edwards Lifesciences (EW) United States $54.208B 38.35
Alcon (ALC) Switzerland $30.150B 25.53
STERIS (STE) Ireland $17.307B 21.50
Teleflex (TFX) United States $9.641B 15.36
Fresenius Medical Care AG KGaA (FMS) Germany $8.287B 7.64
Penumbra (PEN) United States $7.435B 891.96
Globus Medical (GMED) United States $6.225B 31.75
Glaukos (GKOS) United States $2.693B 0.00
Integer Holdings (ITGR) United States $2.196B 17.17
Nevro (NVRO) United States $1.739B 0.00
Paragon 28 (FNA) United States $1.384B 0.00
Artivion (AORT) United States $0.519B 49.50